US2019127425A1PendingUtilityA1
Compositions and methods for insect control
Assignee: UNIV INDIANA RES & TECH CORPPriority: Apr 21, 2016Filed: Apr 21, 2017Published: May 2, 2019
Est. expiryApr 21, 2036(~9.7 yrs left)· nominal 20-yr term from priority
Inventors:Irene Newton
C12N 2310/20C12N 2800/105C07K 14/195C12N 2830/75C12N 15/85C12N 15/62C12N 15/113C12N 2800/22C07K 14/43563Y02A50/30
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are expression vectors encoding the Wolbachia protein WalE1. Also described are insects transformed with an expression vector of the present disclosure, and progeny thereof. Also described are methods for improving Wolbachia replication and transmission in its insect host by overexpressing WalE1 in the insect host. Improved Wolbachia replication and transmission provides for insect population control and pathogen resistance in insects, which can reduce disease transmission.
Claims
exact text as granted — not AI-modified1 . An expression vector comprising a polynucleotide that encodes WalE1 (WD0830) or a functional fragment of WalE1 (WD0830), wherein the polynucleotide is operably linked to an expression control sequence and the expression vector is expressible in an insect.
2 . The expression vector of claim 1 , wherein the insect is Aedes albopictus, Aedes aegypti, Anopheles gamibiae, Anopheles stephansi, Culex ppiens, Culex tarsalis, Culex quinquefasciatus, an insect of the Culicidae family, or an insect of the Drosophilidae family.
3 . The expression vector of claim 1 , wherein the functional fragment of WalE1 (WD0830) comprises a synuclein domain.
4 . The expression vector of claim 3 , wherein the synuclein domain is an alpha-synuclein domain.
5 . The expression vector of claim 1 , wherein the polynucleotide is codon optimized.
6 . The expression vector of claim 1 , wherein WalE1 (WD0830) or the functional fragment of WalE1 (WD0830) comprises a polypeptide having an amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 3-10 and 12-14.
7 . The expression vector of claim 1 , wherein WalE1 (WD0830) has an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO: 2.
8 . The expression vector of claim 1 , wherein the vector is a viral vector.
9 . An insect transformed with the expression vector of claim 1 , or progeny of an insect transformed with the expression vector of claim 1 .
10 . The insect of claim 9 , wherein the insect or progeny of the insect overexpresses WalE1 (WD0830) or a functional fragment of WalE1 (WD0830) relative to an insect that was not transformed with the expression vector.
11 . A method for increasing Wolbachia replication and transmission in an insect population, the method comprising overexpressing WalE1 (WD0830) or a functional fragment of WalE1 (WD0830) in at least one insect capable of breeding with the insect population, and introducing the at least one insect overexpressing WalE1 (WD0830) or a functional fragment of WalE1 (WD0830), or progeny thereof, into the insect population, wherein overexpression is relative to a control insect.
12 . The method of claim 11 , wherein overexpression is achieved by expressing an expression vector in the at least one insect, the expression vector comprises a polynucleotide that encodes WalE1 (WD0830) or a functional fragment of WalE1 (WD0830) and the polynucleotide is operably linked to an expression control sequence
13 . The method of claim 12 , further comprising crossing the at least one insect with at least one other insect to produce progeny overexpressing WalE1 (WD0830) or a functional fragment of WalE1 (WD0830) prior to introducing the at least one insect overexpressing WalE1 (WD0830) or a functional fragment of WalE1 (WD0830) into the insect population.
14 . The method of claim 12 , wherein the functional fragment of WalE1 (WD0830) comprises a synuclein domain.
15 . The method of claim 12 , wherein the synuclein domain is an alpha-synuclein domain.
16 . The method of claim 12 , wherein the polynucleotide is codon optimized.
17 . The method of claim 14 , wherein WalE1 (WD0830) or the function fragment of WalE1 (WD0830) comprises a polypeptide having an amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 3-10 and 12-14.
18 . The method of claim 12 , wherein WalE1 (WD0830) has an amino acid sequence at least 90% identical to the amino acid sequence of SEQ ID NO: 2.
19 . The method of claim 11 , wherein the overexpression is induced in one or more insects harboring Wolbachia prior to the overexpression.
20 . The method of claim 11 , further comprising infecting the at least one insect with Wolbachia before, concurrently with, or after inducing the overexpression.
21 . The method of claim 12 , wherein the pathogen is selected from the group consisting of a virus, a protozoan, and a worm.
22 . The method of claim 21 , wherein the virus is selected from the group consisting of Chikungunya virus, dengue virus, West-Nile virus, Yellow Fever virus.
23 . The method of claim 21 , wherein the protozoan is a malaria parasite of the genus Plasmodium.
24 . The method of claim 21 , wherein the worm is a filarial nematode.
25 . The method of claim 11 , wherein the insect is Aedes albopictus, Aedes aegypti, Anopheles gamibiae, Anopheles stephansi, Culex pipiens, Culex tarsalis, Culex quinquefasciatus, an insect of the Culicidae family, or an insect of the Drosophilidae family.
26 . A method for controlling an insect population, and/or conferring or increasing viral resistance in the insect population, the method comprising expressing the expression vector of claim 1 in at least one insect of the insect population.
27 . A CRISPR-on system comprising dCas9 fused with a transcriptional activation domain, and a single guide RNA (sgRNA) having a complementary nucleic acid sequence to a WalE1 (WD0830) expression control element.Join the waitlist — get patent alerts
Track US2019127425A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.